This website is intended for UK healthcare professionals only Log in | Register

Editorial articles

April 2014 Br J Cardiol 2014;21:47–8 doi:10.5837/bjc.2014.010 Online First

ECG interpretation in the NHS

Derek Rowlands, Philip Moore

Abstract

The first human electrocardiogram (ECG) was recorded over 125 years ago. Despite the development of many new investigative techniques, the ECG remains an essential part of any cardiovascular assessment, whether in relation to acute or chronic health issues, to insurance assessment or to the assessment of risk in critical occupations or in sports professionals. In terms of interpretation, it is fair to say that the ECG occupies a unique and unsatisfactory position. Unlike pathology specimens and the images produced by modern techniques (both of which are always formally reported by trained and tested professionals), and unlike biochemical data (which are usually presented to the user clinician with the normal values displayed), ECGs are most commonly reported and acted upon by front-line users who have had no formal training in, and no assessment of competency in, ECG interpretation, and who generally proceed with no clear guidelines about the limits of normality or the precise criteria for specific abnormalities. There is no formal, national programme for training in ECG interpretation, or for the assessment of ECG interpretation skills. Inevitably, therefore, the standard of ECG interpretation (both in general practice and also in hospital) is highly variable, and is often extremely poor.

| Full text

February 2014 Br J Cardiol 2014;21:7–8 doi:10.5837/bjc.2014.001 Online First

Ageism and coronary angiography

Thomas Green, John Baxter, Sam McClure

Abstract

National life-expectancy is steadily rising with the number of those aged 85 years or over doubling from 1985 to 2010,1 and ever more elderly patients presenting to cardiology. Age is a potent risk factor for mortality after acute coronary syndrome (ACS),2 and older patients with angina present with more severe symptoms and prognostically significant coronary anatomy.3 Age has a very powerful influence on risk stratification tools such as GRACE (Global Registry of Acute Coronary Events), and National Institute for Health and Care Excellence (NICE) guidance supports early invasive investigation and management for high-scoring patients.4 Diagnostic coronary angiography (DCA) is crucial to assessing the cross-spectrum of coronary disease presentation. Despite this, elderly patients are less likely to be treated in accordance with best practice after presenting with ACS,5,6 the so-called ‘risk paradox’. Concern about the safety and efficacy of DCA and percutaneous coronary intervention (PCI) in the more elderly population seems to underpin this behaviour. 

There is in fact a wealth of data to indicate that DCA in the elderly has acceptable complication rates,7 and that revascularisation, surgical or by PCI, offers significant benefit.5 The study by Walsh and Hargreaves (see page 37) is welcome in further describing the fallacies of current practice, which fall short of best practice.6 

| Full text
Renal sympathetic denervation: cautious optimism and careful next steps

December 2013 Br J Cardiol 2013;20:128–29 doi:10.5837/bjc.2013.32

Renal sympathetic denervation: cautious optimism and careful next steps

Melvin D Lobo

Abstract

Despite the high and growing prevalence of hypertension worldwide, and the increasing attention focused on the challenge of resistant hypertension (RHTN), it is somewhat extraordinary to note the lack of data attesting to the epidemiology and management of RHTN at the present time. Few studies have described the incidence and prevalence of this condition, yet, it is very clear that, once diagnosed with RHTN, patients are at strikingly elevated risk of cardiovascular events, and thus clearly defined treatment strategies are urgently required.1 Quite remarkably, when reviewing the evidence base in RHTN for the recent National Institute for Health and Care Excellence (NICE) hypertension guidelines, the authors could find just one head-to-head randomised-controlled trial in this patient cohort, and only six retrospective cohort studies, with the largest being a post hoc analysis of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) study, where the use of spironolactone as a fourth-line agent was associated with blood pressure (BP) reductions of ~20/10 mmHg.2 Currently, we are hopeful that trials, such as the British Hypertension Society (BHS)-led Pathway 2 study (UKCRN.org.uk ID 4500) and the Resistant Hypertension Optimal Treatment (ReHOT) study (Clinicaltrials.gov ID NCT01643434), will help improve our drug therapy of RHTN. Nonetheless, it should be recognised that, while pharmacotherapy of hypertension is proven (at least up until the point of RHTN), issues with physician inertia, poor concordance and drug intolerance continue to undermine our efforts to get patients to target BP. 

| Full text
Islam and the cardiovascular patient – pragmatism in practice

July 2013 Br J Cardiol 2013;20:90–1 doi:10.5837/bjc.2013.020 Online First

Islam and the cardiovascular patient – pragmatism in practice

Hassan Chamsi-Pasha

Abstract

Muslims worldwide represent a diverse and heterogeneous population varying widely in terms of geographical distribution, language, lifestyle, habits, customs, tradition, dietary habits and, above all, socio-economic status, which has a major influence on all other factors.1

| Full text

July 2013 Br J Cardiol 2013;20:88-9 doi:10.5837/bjc.2013.023 Online First

Cardiac magnetic resonance imaging in the UK – an end to status anxiety but no room for complacency

Charlotte Manisty, James C Moon

Abstract

As UK cardiologists, we might be forgiven for assuming acceptance of cardiovascular magnetic resonance (CMR). The past decade has seen CMR in the UK change from an ancillary research/specialist patient populations tool to an evidence-based imaging modality for use in all spheres of cardiovascular disease. Within the wider medical community and overseas, however, the advantages of CMR remain opaque.

| Full text

June 2013 Br J Cardiol 2013;20:45–6 doi:10.5837/bjc.2013.14

Reducing the cost of heart failure while improving quality of life

Richard Brown, Andrew L Clark

Abstract

Chronic heart failure (CHF) affects 900,000 people in the UK and consumes almost 2% of the National Health Service (NHS) budget. These figures are set to rise as the prognosis of coronary artery disease improves and the population ages. Heart failure currently accounts for approximately 5% of all emergency medical admissions to hospital, and over the next 25 years the proportion will rise by 50% – largely due to an older population.1 

| Full text
The emergence of the CVGP 

June 2013 Br J Cardiol 2013;20:47 doi:10.5837/bjc.2013.15

The emergence of the CVGP 

Ahmet Fuat, Kathryn E Griffith

Abstract

The National GPSI Cardiology Forum was established in 2005 and, despite the demise of the Primary Care Cardiovascular Society (PCCS) to which it was affiliated, it has remained active in the national cardiovascular arena. At a recent meeting at Warwick University, a decision was made to change our name to CVGP (CardioVascular General Practitioners: the Society for GPs with an interest in Cardiovascular Medicine). This name change does not alter our stated aims or direction of travel, but acknowledges the need to embrace all GPs involved in cardiovascular care rather than just GPs with a special interest (GPSIs) in cardiology. We believe this is essential in the evolving NHS clinical commissioning environment. 

| Full text
The SERVE-HF study: investigating the impact of central sleep apnoea on heart failure

April 2013 Br J Cardiol 2013;20:50–1 doi:10.5837/bjc.2013.011 Online First

The SERVE-HF study: investigating the impact of central sleep apnoea on heart failure

Martin Cowie

Abstract

When reference is made to sleep-disordered breathing (SDB), obstructive sleep apnoea (OSA) often springs to mind. Indeed, much research has been centred on identifying individuals at risk of OSA, determining the most effective form of therapy and unearthing the manner by which OSA increases cardiovascular disease (CVD) risk. As a result, factors such as central adiposity, neck circumference and age have been identified as OSA risk factors, and continuous positive airway pressure (CPAP) has become a well-recognised treatment for OSA. Studies also indicate that OSA may increase CVD risk via mechanisms involving tissue hypoxia and increased sympathetic nervous system activity, and that CPAP therapy counteracts these mechanisms.1 The case for the OSA–CVD link has been further strengthened by additional research showing that CPAP can reduce elevated blood pressure and reduce the risk of cardiovascular events, such as heart attack and stroke.2,3

| Full text
Is training shaping up?

April 2013 Br J Cardiol 2013;20:48–9 doi:10.5837/bjc.2013.010 Online First

Is training shaping up?

John Ian Wilson, Jim Hall

Abstract

The Cardiology Curriculum1 describes the specialty of cardiology as a subspecialisation for physicians who were predominantly concerned with the care of patients with cardiovascular disorders. It goes on to state that care of such patients embraces a wide range of clinical activities and cardiologists need a broad view of the cardiovascular needs of individual patients and the communities in which they live, including an understanding of any prevailing health inequalities. This requires knowledge of not only the diagnostic and therapeutic modalities available, but also an appreciation of the importance of the epidemiology and potential for prevention of cardiovascular disease. Although cardiology is generally stereotyped as a highly practical skill-based medical specialty, with invasive and interventional skills as high-profile components of the workload, competence in other areas of practice such as cardiovascular clinical pharmacology and non-invasive imaging are equally important.

| Full text
The BJC – leading opinion for 20 years

March 2013 Br J Cardiol 2013;20:5 doi:10.5837/bjc.2013.003

The BJC – leading opinion for 20 years

Abstract

Twenty years ago, when we launched the British Journal of Cardiology (BJC) our intention was to produce a peer-reviewed journal, which linked cardiologists and general practitioners (GPs) with an interest in cardiovascular medicine. We have not waivered and, indeed, have grown to be a unique publication widely read across both primary and secondary care, leading opinion for 20 years.

| Full text




Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now